BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28949121)

  • 21. Whole-exome sequencing studies of parathyroid carcinomas reveal novel PRUNE2 mutations, distinctive mutational spectra related to APOBEC-catalyzed DNA mutagenesis and mutational enrichment in kinases associated with cell migration and invasion.
    Yu W; McPherson JR; Stevenson M; van Eijk R; Heng HL; Newey P; Gan A; Ruano D; Huang D; Poon SL; Ong CK; van Wezel T; Cavaco B; Rozen SG; Tan P; Teh BT; Thakker RV; Morreau H
    J Clin Endocrinol Metab; 2015 Feb; 100(2):E360-4. PubMed ID: 25387265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parathyroid Carcinoma: Diagnosis and Clinical Implications.
    Duan K; Mete Ö
    Turk Patoloji Derg; 2015; 31 Suppl 1():80-97. PubMed ID: 26177319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and somatic mutations of SDHAF2 (SDH5), a novel endocrine tumor suppressor gene in parathyroid tumors of primary hyperparathyroidism.
    Starker LF; Delgado-Verdugo A; Udelsman R; Björklund P; Carling T
    Endocrine; 2010 Dec; 38(3):397-401. PubMed ID: 20972721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidism.
    Bricaire L; Odou MF; Cardot-Bauters C; Delemer B; North MO; Salenave S; Vezzosi D; Kuhn JM; Murat A; Caron P; Sadoul JL; Silve C; Chanson P; Barlier A; Clauser E; Porchet N; Groussin L;
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E403-8. PubMed ID: 23293331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel somatic MEN1 gene alterations in sporadic primary hyperparathyroidism and correlation with clinical characteristics.
    Scarpelli D; D'Aloiso L; Arturi F; Scillitani A; Presta I; Bisceglia M; Cristofaro C; Russo D; Filetti S
    J Endocrinol Invest; 2004 Dec; 27(11):1015-21. PubMed ID: 15754732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomic profiling reveals mutational landscape in parathyroid carcinomas.
    Pandya C; Uzilov AV; Bellizzi J; Lau CY; Moe AS; Strahl M; Hamou W; Newman LC; Fink MY; Antipin Y; Yu W; Stevenson M; Cavaco BM; Teh BT; Thakker RV; Morreau H; Schadt EE; Sebra R; Li SD; Arnold A; Chen R
    JCI Insight; 2017 Mar; 2(6):e92061. PubMed ID: 28352668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Large retrosternal parathyroid carcinoma with primary hyperparathyroidism.
    Tan GC; Shiran MS; Swaminathan M; Phang KS; Rohaizak M
    Asian J Surg; 2007 Oct; 30(4):286-9. PubMed ID: 17962134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early-onset, severe, and recurrent primary hyperparathyroidism associated with a novel CDC73 mutation.
    Shibata Y; Yamazaki M; Takei M; Uchino S; Sakurai A; Komatsu M
    Endocr J; 2015; 62(7):627-32. PubMed ID: 25959515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Primary hyperparathyroidism].
    Carnevale V; Romagnoli E; Pipino M; Scillitani A; D'Erasmo E; Minisola S; Mazzuoli G
    Clin Ter; 2005; 156(5):211-26. PubMed ID: 16382970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parathyroid cancer: An update.
    Rodrigo JP; Hernandez-Prera JC; Randolph GW; Zafereo ME; Hartl DM; Silver CE; Suárez C; Owen RP; Bradford CR; Mäkitie AA; Shaha AR; Bishop JA; Rinaldo A; Ferlito A
    Cancer Treat Rev; 2020 Jun; 86():102012. PubMed ID: 32247225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CDC73-Related Disorders: Clinical Manifestations and Case Detection in Primary Hyperparathyroidism.
    van der Tuin K; Tops CMJ; Adank MA; Cobben JM; Hamdy NAT; Jongmans MC; Menko FH; van Nesselrooij BPM; Netea-Maier RT; Oosterwijk JC; Valk GD; Wolffenbuttel BHR; Hes FJ; Morreau H
    J Clin Endocrinol Metab; 2017 Dec; 102(12):4534-4540. PubMed ID: 29040582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of malignant parathyroid tumours in two European cohorts of patients with sporadic primary hyperparathyroidism.
    Ozolins A; Narbuts Z; Vanags A; Simtniece Z; Visnevska Z; Akca A; Wirowski D; Gardovskis J; Strumfa I; Goretzki PE
    Langenbecks Arch Surg; 2016 Nov; 401(7):943-951. PubMed ID: 26658808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MEN1 intragenic deletions may represent the most prevalent somatic event in sporadic primary hyperparathyroidism.
    Alvelos MI; Vinagre J; Fonseca E; Barbosa E; Teixeira-Gomes J; Sobrinho-Simões M; Soares P
    Eur J Endocrinol; 2013 Feb; 168(2):119-28. PubMed ID: 23093699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical, genetic, and histopathologic investigation of CDC73-related familial hyperparathyroidism.
    Masi G; Barzon L; Iacobone M; Viel G; Porzionato A; Macchi V; De Caro R; Favia G; Palù G
    Endocr Relat Cancer; 2008 Dec; 15(4):1115-26. PubMed ID: 18755853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Familial Hyperparathyroidism - Disorders of Growth and Secretion in Hormone-Secretory Tissue.
    Marx SJ; Lourenço DM
    Horm Metab Res; 2017 Nov; 49(11):805-815. PubMed ID: 29136674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathological correlates of hyperparathyroidism.
    Duan K; Gomez Hernandez K; Mete O
    J Clin Pathol; 2015 Oct; 68(10):771-87. PubMed ID: 26163537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Familial isolated primary hyperparathyroidism/hyperparathyroidism-jaw tumour syndrome caused by germline gross deletion or point mutations of CDC73 gene in Chinese.
    Kong J; Wang O; Nie M; Shi J; Hu Y; Jiang Y; Li M; Xia W; Meng X; Xing X
    Clin Endocrinol (Oxf); 2014 Aug; 81(2):222-30. PubMed ID: 24716902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [An uncommon cause of hypercalcemia: synchronous carcinoma of two parathyroids in the context of hyperparathyroidism-jaw tumor syndrome].
    Veiguela B; Isidro ML; Jorge S; Ruano B
    Endocrinol Nutr; 2010 Oct; 57(8):391-3. PubMed ID: 20483674
    [No Abstract]   [Full Text] [Related]  

  • 39. Surveillance for early detection of aggressive parathyroid disease: carcinoma and atypical adenoma in familial isolated hyperparathyroidism associated with a germline HRPT2 mutation.
    Kelly TG; Shattuck TM; Reyes-Mugica M; Stewart AF; Simonds WF; Udelsman R; Arnold A; Carpenter TO
    J Bone Miner Res; 2006 Oct; 21(10):1666-71. PubMed ID: 16995822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Parathyroid carcinoma. Therapeutic strategies derived from 20 years of experience].
    Pelizzo MR; Piotto A; Bergamasco A; Rubello D; Casara D
    Minerva Endocrinol; 2001 Mar; 26(1):23-9. PubMed ID: 11323564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.